Further analyses of the larger TCGA dataset revealed that a high SAA/ALOX5 ratio in tumours is not exclusive to KRAS mutated tumours, as high levels were detected in TP53 and LKB1 mutated tumours. The gene discussed is KRAS; the disease is neoplasm.